Similar articles for PMID: 10955785

Year	Number of Results
1949	1
1954	1
1955	1
1961	1
1965	2
1966	2
1967	1
1968	2
1969	2
1970	1
1971	1
1973	2
1974	1
1979	1
1980	1
1982	4
1983	6
1984	4
1985	5
1986	5
1987	1
1988	5
1989	4
1990	2
1991	3
1992	3
1993	5
1994	14
1995	8
1996	20
1997	14
1998	19
1999	14
2000	12
2001	8
2002	9
2003	9
2004	18
2005	13
2006	10
2007	7
2008	14
2009	19
2010	16
2011	9
2012	10
2013	9
2014	19
2015	6
2016	8
2017	10
2018	5
2019	7
2020	7
2021	11
2022	8
2023	4
2024	0

1

A phase I-II study of isolated hepatic perfusion using melphalan with or without tumor necrosis factor for patients with ocular melanoma metastatic to liver.

Alexander HR, Libutti SK, Bartlett DL, Puhlmann M, Fraker DL, Bachenheimer LC. Alexander HR, et al. Clin Cancer Res. 2000 Aug;6(8):3062-70. Clin Cancer Res. 2000. PMID: 10955785 Clinical Trial.

2

Hyperthermic isolated hepatic perfusion using melphalan for patients with ocular melanoma metastatic to liver.

Alexander HR Jr, Libutti SK, Pingpank JF, Steinberg SM, Bartlett DL, Helsabeck C, Beresneva T. Alexander HR Jr, et al. Clin Cancer Res. 2003 Dec 15;9(17):6343-9. Clin Cancer Res. 2003. PMID: 14695133 Clinical Trial.

3

Isolated hepatic perfusion with high-dose melphalan results in immediate alterations in tumor gene expression in patients with metastatic ocular melanoma.

Varghese S, Xu H, Bartlett D, Hughes M, Pingpank JF, Beresnev T, Alexander HR Jr. Varghese S, et al. Ann Surg Oncol. 2010 Jul;17(7):1870-7. doi: 10.1245/s10434-010-0998-z. Epub 2010 Mar 11. Ann Surg Oncol. 2010. PMID: 20221901

4

Isolated hypoxic hepatic perfusion with melphalan in patients with irresectable ocular melanoma metastases.

van Etten B, de Wilt JH, Brunstein F, Eggermont AM, Verhoef C. van Etten B, et al. Eur J Surg Oncol. 2009 May;35(5):539-45. doi: 10.1016/j.ejso.2008.07.004. Epub 2008 Aug 28. Eur J Surg Oncol. 2009. PMID: 18760560

5

Hepatic vascular isolation and perfusion for patients with progressive unresectable liver metastases from colorectal carcinoma refractory to previous systemic and regional chemotherapy.

Alexander HR Jr, Libutti SK, Bartlett DL, Pingpank JF, Kranda K, Helsabeck C, Beresnev T. Alexander HR Jr, et al. Cancer. 2002 Aug 15;95(4):730-6. doi: 10.1002/cncr.10686. Cancer. 2002. PMID: 12209715 Free article.

6

Augmented capillary leak during isolated hepatic perfusion (IHP) occurs via tumor necrosis factor-independent mechanisms.

Alexander HR, Brown CK, Bartlett DL, Libutti SK, Figg WD, Raje S, Turner E. Alexander HR, et al. Clin Cancer Res. 1998 Oct;4(10):2357-62. Clin Cancer Res. 1998. PMID: 9796965

7

Isolated hepatic perfusion for the treatment of patients with advanced liver metastases from pancreatic and gastrointestinal neuroendocrine neoplasms.

Grover AC, Libutti SK, Pingpank JF, Helsabeck C, Beresnev T, Alexander HR Jr. Grover AC, et al. Surgery. 2004 Dec;136(6):1176-82. doi: 10.1016/j.surg.2004.06.044. Surgery. 2004. PMID: 15657573 Clinical Trial.

8

[Isolated hyperthermic limb perfusion with melphalan and tumor necrosis factor in malignant melanoma].

Kettelhack C, Hohenberger P, Schlag PM. Kettelhack C, et al. Dtsch Med Wochenschr. 1997 Feb 14;122(7):177-81. doi: 10.1055/s-2008-1047593. Dtsch Med Wochenschr. 1997. PMID: 9072487 German.

9

Randomized multicenter trial of hyperthermic isolated limb perfusion with melphalan alone compared with melphalan plus tumor necrosis factor: American College of Surgeons Oncology Group Trial Z0020.

Cornett WR, McCall LM, Petersen RP, Ross MI, Briele HA, Noyes RD, Sussman JJ, Kraybill WG, Kane JM 3rd, Alexander HR, Lee JE, Mansfield PF, Pingpank JF, Winchester DJ, White RL Jr, Chadaram V, Herndon JE 2nd, Fraker DL, Tyler DS; American College of Surgeons Oncology Group Trial Z0020. Cornett WR, et al. J Clin Oncol. 2006 Sep 1;24(25):4196-201. doi: 10.1200/JCO.2005.05.5152. J Clin Oncol. 2006. PMID: 16943537 Clinical Trial.

10

Isolated hepatic perfusion with tumor necrosis factor and melphalan for unresectable cancers confined to the liver.

Alexander HR Jr, Bartlett DL, Libutti SK, Fraker DL, Moser T, Rosenberg SA. Alexander HR Jr, et al. J Clin Oncol. 1998 Apr;16(4):1479-89. doi: 10.1200/JCO.1998.16.4.1479. J Clin Oncol. 1998. PMID: 9552055 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

370 results

Results by year